RNAZ
TRANSCODE THERAPEUTICS INC
CUSIP: 89357L501
TRANSCODE THERAPEUTICS INC (RNAZ) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
TransCode Therapeutics, Inc. is a biotechnology company focused on developing nucleic acid therapeutics and proprietary delivery technologies aimed at improving the targeted delivery and intracellular uptake of RNA-based drugs. As an early-stage player in the RNA therapeutics and drug-delivery sector, the company’s market position depends on advancing preclinical and clinical validation of its platform and securing partnerships or licensing deals with larger pharmaceutical firms.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...